Free Trial
TSE:HBP

Helix BioPharma (HBP) Stock Price, News & Analysis

Helix BioPharma logo
C$3.95 +1.04 (+35.74%)
As of 10/3/2025 03:58 PM Eastern

About Helix BioPharma Stock (TSE:HBP)

Advanced

Key Stats

Today's Range
C$2.78
C$4.25
50-Day Range
C$0.98
C$3.95
52-Week Range
C$0.50
C$4.25
Volume
56,753 shs
Average Volume
6,568 shs
Market Capitalization
C$301.69 million
P/E Ratio
N/A
Dividend Yield
1.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HBP Stock News Headlines

Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
Helix BioPharma Corp.
Helix Biopharma Corp. Announces Issuance of U.S. Patent
See More Headlines

HBP Stock Analysis - Frequently Asked Questions

Helix BioPharma's stock was trading at C$0.89 at the start of the year. Since then, HBP shares have increased by 343.8% and is now trading at C$3.95.

Helix BioPharma Corp. (TSE:HBP) posted its earnings results on Thursday, October, 24th. The biopharmaceutical company reported ($0.11) earnings per share (EPS) for the quarter.

Shares of HBP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Helix BioPharma investors own include Enterprise Products Partners (EPD), GrowGeneration (GRWG), Green Thumb Industries (GTBIF), Amplify Seymour Cannabis ETF (CNBS), Cenovus Energy (CVE), Enbridge (ENB) and Micron Technology (MU).

Company Calendar

Last Earnings
10/24/2024
Today
10/05/2025

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:HBP
CIK
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($1.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$50.55 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
1,803.57%
Return on Assets
-279.98%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.23
Quick Ratio
1.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.35 per share
Price / Cash Flow
11.32
Book Value
C($0.14) per share
Price / Book
-28.39

Miscellaneous

Outstanding Shares
76,378,000
Free Float
N/A
Market Cap
C$301.69 million
Optionable
Not Optionable
Beta
0.12
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (TSE:HBP) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners